The correspondent impugned the efficacy of the AOD9604...

The correspondent impugned the efficacy of the AOD9604 compound,a decade of research (or worse the good character of prof Greenwood ,a distinguished clinician and researcher) by suggesting their compound/research/partnering was snake oil as compared to anti cellulite cream which is not. Really?

There is a country mile difference between a Phase 2 clinical trial (probity rules, several million dollars and statistical significance) and a subjective evaluation by end users and photoshop, sorry high end photo analysis.
Actually there is probably some IP in developing this for skin cancer detection.

This is not to say the cream is not worthy of inclusion in the top ten anti cellulite products.
Perhaps a dermatologist could shed some light.

In reference to the amount of royalties CZD has received from POH it was a CZD thread in hot copper some months ago and the post was unchallenged. The poster advised much digging of accounts was required. As stated it was the first year’s royalties and as yet this years are unknown. If any updated information is available then please share it with the market.
POH is otherwise an excellent de risked Biotech.
A bit of silly un sophisticated commentary is always welcome unless of course you’re hard urned is at risk if unchallenged.
Pharmaceuticals in the racing game? Watch this space.